Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
July 1, 2019 Off

Top 5 Vendors in the Global Bone Cancer Drugs Market 2019-2023 | Technavio

By BusinessWire

LONDON–(BUSINESS WIRE)–#Research–The emergence of targeted therapies for the treatment of bone cancer is expected to drive market growth. Currently, targeted…

July 1, 2019 Off

Merck to Hold Second-Quarter 2019 Sales and Earnings Conference Call on July 30

By BusinessWire

KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its second-quarter 2019 sales…

July 1, 2019 Off

Bristol-Myers Squibb Completes Divestment of UPSA

By BusinessWire

NEW YORK–(BUSINESS WIRE)–$BMY—Bristol-Myers Squibb Company (NYSE:BMY) announced today that effective July 1, 2019 it has completed its previously announced divestment…

July 1, 2019 Off

Terns Pharmaceuticals Appoints Ankang Li, Ph.D., J.D., CFA as Chief Financial Officer

By BusinessWire

FOSTER CITY, Calif. & SHANGHAI–(BUSINESS WIRE)–Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to…

Pfizer Announces Results from Phase 3 Trial of Revatio® (Sildenafil Citrate) in Newborns with Persistent Pulmonary Hypertension
June 30, 2019 Off

Pfizer Announces Results from Phase 3 Trial of Revatio® (Sildenafil Citrate) in Newborns with Persistent Pulmonary Hypertension

By BusinessWire

Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study to assess the efficacy and safety of intravenous (IV) sildenafil when added to inhaled nitric oxide (iNO) for the treatment of newborns with Persistent Pulmonary Hypertension (PPHN) did not meet its primary efficacy endpoint.

Acerus Announces Amendment to Term Loan Credit Facility
June 30, 2019 Off

Acerus Announces Amendment to Term Loan Credit Facility

By BusinessWire

Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB: ASPCF) (“Acerus” or the “Company”) today announced that it entered into an amended agreement related to its existing credit facility with SWK Funding LLC

June 28, 2019 Off

Global Psoriatic Arthritis Market Spotlight 2019-2029 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Psoriatic Arthritis” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the psoriatic…

June 28, 2019 Off

Quanterix Announces Kevin Hrusovsky, Chairman and Chief Executive Officer, and Founder of Powering Precision Health, as EY Entrepreneur Of The Year® 2019 Award Winner in New England

By BusinessWire

BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health,…

June 28, 2019 Off

June 27 is National HIV Testing Day: AscellaHealth High-Touch Specialty Pharmacy Solutions Improve Outcomes and Quality of Life

By BusinessWire

BERWYN, Pa.–(BUSINESS WIRE)–In recognition of the importance of HIV testing and early diagnosis of HIV, AscellaHealth, a specialty-focused pharmaceutical management…

June 28, 2019 Off

Global $13.3Bn Cephalosporin Market by Generation, Route of Administration, Application, and Region – Forecast to 2024 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Cephalosporin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s…

Posts pagination

Previous 1 … 3,036 3,037 3,038 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine